You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
塞力醫療(603716.SH)擬認購Levitas 27.48%股權 並與其共同設立子公司
格隆匯 12-30 22:05

格隆匯12月30日丨塞力醫療(603716.SH)公佈,公司與美國Levitas,Inc.(以下簡稱“Levitas”)簽署股權認購協議,公司認購Levitas 27.48%股權,總認購出資額1500萬美元。

同時公司與Levitas簽署合資協議,雙方共同出資500萬美元在中國設立合資公司立維拓生物技術(上海)有限公司(以登記機關最終核准的名稱為準,以下簡稱“立維拓生物技術”),其中公司以貨幣出資255萬美元持股51%;Levitas以知識產權出資245萬美元持股49%。

公司主要業務涵蓋體外診斷試劑研發生產,本次對外投資及新設子公司,有利於豐富公司產品及服務體系,與公司SPD等集約化運營服務業務產生較好的上下游協同效應。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account